Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ID93+GLA-SE in BCG-Vaccinated Healthy Healthcare Workers
NCT03806686Phase 2Unknown
- Sponsor
- Quratis
- Start
- May 2018
- Primary completion
- Mar 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ID93 + GLA-SE in Tuberculosis (TB), sponsored by Quratis. Status: unknown.
02
Drugs
ID93 + GLA-SE
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03806686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03806686.